Salvage Radiotherapy After Radical Prostatectomy
SRT
Changes in Bladder Function After Surgery and Radiation Therapy for Prostate Cancer
1 other identifier
observational
70
0 countries
N/A
Brief Summary
The purpose of this study is to describe the urinary morbidity as a result surgery and radiation therapy, in patients treated for prostate cancer. All the patients will undergo a Urodynamic examination to verify the grade of Urinary morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedFirst Posted
Study publicly available on registry
November 5, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedNovember 5, 2015
October 1, 2015
8 months
October 7, 2015
November 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Spontaneous urinary flow
The patients load the water at a special flow toilet
2 minutes
Biomechanical properties of urethra
Evaluation of biomechanical wall properties by measuring luminal cross-sectional area and pressure.
10 minutes
Cystometri
The bladder is filled with saline with a flow rate of 60 mL/minute.
20 minutes
Uretal pressure profile
To evaluate the uretal pressure profile. The water pump perfused saline at a flow rate of 1 mL, while the catheter. attached to an automatic pulling device, was pulled out of the urethra at 2 mm/s.
10 minutes
Study Arms (1)
Urodynamics
There is no intervention in this study.
Eligibility Criteria
The patients in this cohort had surgery for prostate cancer in the period from 1999-2009. Because of a locale disease relapse the patients were treated with Salvage radiation therapy in the period from 2006-2010.
You may qualify if:
- Patients treated with salvage radiotherapy at Aarhus University hospital in the period from 2006-2010.
You may not qualify if:
- Other cancer types
- Severe comorbidity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Michael Borre, Professor
University of Aarhus
- STUDY CHAIR
Morten Høyer, Professor
University of Aarhus
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2015
First Posted
November 5, 2015
Study Start
November 1, 2015
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
November 5, 2015
Record last verified: 2015-10